IRIS
BRUNETTI, Lorenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.232
EU - Europa 1.411
AS - Asia 1.123
SA - Sud America 195
Continente sconosciuto - Info sul continente non disponibili 124
AF - Africa 49
OC - Oceania 2
Totale 5.136
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.176
RU - Federazione Russa 787
SG - Singapore 370
VN - Vietnam 223
IT - Italia 182
CN - Cina 171
HK - Hong Kong 158
BR - Brasile 149
IE - Irlanda 105
FR - Francia 78
SE - Svezia 77
GB - Regno Unito 66
IN - India 54
DE - Germania 34
BD - Bangladesh 29
CA - Canada 26
FI - Finlandia 22
ID - Indonesia 20
ZA - Sudafrica 19
AR - Argentina 16
NL - Olanda 14
TR - Turchia 12
AT - Austria 10
CI - Costa d'Avorio 10
PH - Filippine 10
JP - Giappone 9
MX - Messico 9
PK - Pakistan 9
BE - Belgio 8
IQ - Iraq 7
KR - Corea 7
MA - Marocco 7
PL - Polonia 7
TH - Thailandia 7
CO - Colombia 6
VE - Venezuela 6
CL - Cile 5
EC - Ecuador 5
ES - Italia 5
MY - Malesia 5
PS - Palestinian Territory 5
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
LT - Lituania 4
PY - Paraguay 4
SV - El Salvador 4
DO - Repubblica Dominicana 3
JO - Giordania 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
UA - Ucraina 3
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
ML - Mali 1
MT - Malta 1
PE - Perù 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.012
Salva come PNG Salva come JPEG
Città #
Ashburn 463
Chandler 338
Singapore 220
San Jose 164
Hong Kong 152
Council Bluffs 100
Dublin 99
Dallas 97
Boardman 81
The Dalles 75
Ho Chi Minh City 62
Fairfield 48
Hanoi 48
Lauterbourg 46
Ancona 40
Los Angeles 40
Beijing 37
Lawrence 35
Moscow 35
Princeton 35
Pune 33
Boston 32
Wilmington 30
Cambridge 26
Milan 24
New York 24
Helsinki 21
London 20
São Paulo 20
Des Moines 16
Houston 16
Buffalo 15
Montesilvano Marina 15
Santa Clara 14
Shanghai 14
Chicago 13
Nuremberg 13
Columbus 12
Frankfurt am Main 12
Jakarta 12
Bologna 11
Hefei 11
Johannesburg 11
Seattle 11
Washington 11
Abidjan 10
Haiphong 10
Woodbridge 10
Atlanta 9
San Diego 9
Tokyo 9
Brooklyn 8
Brussels 8
Da Nang 8
Haikou 8
Denver 7
Guangzhou 7
Miano 7
Montreal 7
Salt Lake City 7
San Francisco 7
Hải Dương 6
Manchester 6
Rome 6
San Vitaliano 6
Warsaw 6
Amsterdam 5
Bangkok 5
Can Tho 5
Orem 5
Porto Alegre 5
Rio de Janeiro 5
Roubaix 5
Ankara 4
Ann Arbor 4
Biên Hòa 4
Elk Grove Village 4
Jiaxing 4
Kuala Selangor 4
Mexico City 4
Miami 4
Phoenix 4
Poplar 4
San Salvador 4
Seoul 4
Thái Nguyên 4
Vienna 4
Acton 3
Amman 3
Belém 3
Brescia 3
Charlotte 3
Guarulhos 3
Istanbul 3
Kingston 3
Managua 3
Manila 3
Mumbai 3
Nairobi 3
Panama City 3
Totale 2.943
Salva come PNG Salva come JPEG
Nome #
Highly efficient gene disruption of murine and human hematopoietic progenitor cells by CRISPR/Cas9 695
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 168
NPM1-mutated acute myeloid leukemia: From bench to bedside 147
Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia 146
How I diagnose and treat NPM1-mutated AML 124
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression 122
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 116
Breast Cancer With Release of Tumor Cells in Peripheral Blood Mimicking Acute Myeloid Leukemia 115
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells 112
Mutant NPM1 Maintains the Leukemic State through HOX Expression 111
Current status and future perspectives in targeted therapy of NPM1-mutated AML 107
Aerobic Plus Resistance Exercise in Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Weight Loss 106
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy 106
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics 102
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 101
DNMT3A in Leukemia 97
Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field 96
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 95
CD123 is consistently expressed on NPM1-mutated AML cells 92
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome 90
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9 87
NOVEL NPM1 EXON 5 MUTATIONS AND GENE FUSIONS LEADING TO ABERRANT CYTOPLASMIC NUCLEOPHOSMIN IN AML 86
Nutrient-sensitive transcription factors TFEB and TFE3 couple autophagy and metabolism to the peripheral clock 84
Effect of the COVID-19 pandemic on laboratory and clinical research: A testimony and a call to action from researchers 84
CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells: Correspondence 82
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells 82
TFEB regulates murine liver cell fate during development and regeneration 79
An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant 76
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion 75
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities 75
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 75
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 73
Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor 73
AML-099 Prolonged XPO1 Inhibition Is Essential for Optimal Anti-Leukemic Activity in NPM1-Mutated AML 72
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice 71
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: A shared clonal origin 71
Response to: “Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” 71
Dactinomycin in NPM1-Mutated acute myeloid leukemia 70
Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma 68
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 66
New insights into the biology of acute myeloid leukemia with mutated NPM1 66
Overlapping features of therapy-related and de novoNPM1-mutated AML 65
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis 65
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A 65
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells 64
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1 61
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 58
NPM1-mutated AML with starry sky pattern 57
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 53
The NPM1 mutant defines AML irrespective of blast count 46
Prolonged XPO1 inhibition is essential for optimal anti-leukemic activity in NPM1-mutated AML 45
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia 32
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents 32
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation 26
Disparate leukemia mutations converge on nuclear phase-separated condensates 11
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351 9
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort 9
Nuclear Transcriptional Condensates as Drivers and Therapeutic Targets in NPM1-mutated AML 4
Totale 5.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.842
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022288 0 18 0 0 53 48 1 11 49 8 22 78
2022/2023689 67 80 49 77 49 64 6 57 171 2 29 38
2023/2024969 80 15 37 50 48 205 130 132 77 98 56 41
2024/2025790 77 75 13 18 19 45 72 59 175 44 92 101
2025/20262.252 93 108 157 78 209 195 474 220 265 229 102 122
2026/2027145 80 65 0 0 0 0 0 0 0 0 0 0
Totale 5.136